FTC sues big pharmacy advantage administrators over insulin selling prices The agency introduced motion from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record cost of daily life-conserving insulin medications. Financial commitment in digital wellbeing businesses reached several years-low stages last yr https://label-the-figure-with-the16119.suomiblog.com/the-2-minute-rule-for-healthcare-news-46312742